Luye Pharma’s Rivastigmine Multi-Day Transdermal Patch Receives Marketing Approval in the...

For the treatment of mild to moderate dementia associated with Alzheimer’s disease

Luye Pharma’s Goserelin Microsphere Formulation Meets Preset Endpoints in Phase III Clini...

New Indication for Boan Biotech’s Boyounuo (Bevacizumab Injection) Approved in China

Treatment of Recurrent Glioblastoma

The Third Asia Pacific Psychiatry Symposium Takes Place

Over One Thousand Psychiatrists Gather to Discuss the Diagnosis and Treatment of Mental Disorders During COVID...

Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therap...

Luye Life Sciences Group Shanghai Office Relocation Notice

Luye Life Sciences Group Shanghai Office will be relocated to Hongqiao Road 1438, Changning District from June...